Victory Capital Management
FENC icon

Victory Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Victory Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,466
Closed -$110K – 2770
2020
Q1 		$110K Buy
18,466
+12,128
+191% +$79.1K ﹤0.01% 2508
2019
Q4 		$41K Sell
6,338
-3,009
-32% -$16.2K ﹤0.01% 2608
2019
Q3 		$45K Buy
+9,347
New +$41.2K ﹤0.01% 2730

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Victory Capital Management's FENC Position: Q2 2020 in Review

Victory Capital Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2020, closing a stake of 18,466 shares — an estimated $110K sold.

Victory Capital Management first reported a position in FENC in Q3 2019 and held it in 3 quarters. The position peaked at $110K in Q1 2020. 55 funds tracked by Wall St. Rank hold FENC as of Q2 2020.

  • Victory Capital Management reported no remaining Fennec Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 18,466 Fennec Pharmaceuticals shares in Q2 2020, an estimated $110K.
  • Victory Capital Management first reported a position in Fennec Pharmaceuticals in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Fennec Pharmaceuticals position peaked at $110K in Q1 2020.
  • 55 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.